Investigating how prostate cancer cells change and become resistant to treatment
Studies on Lineage Plasticity in Prostate Cancer
This study is looking at how prostate cancer cells can change and become resistant to treatments, and it's for patients with advanced prostate cancer who want to know if there are ways to make their current therapies work better again.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10877990 on NIH RePORTER |
What this research studies
This research focuses on understanding how prostate cancer cells can change their characteristics, leading to treatment resistance. The team will explore the molecular mechanisms behind this process, particularly how certain signaling pathways contribute to these changes. By using advanced techniques like CRISPR and ATAC sequencing, they aim to identify potential targets for reversing this resistance. The ultimate goal is to find ways to restore sensitivity to existing therapies for patients with advanced prostate cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with castrate-resistant prostate cancer who have experienced treatment failure.
Not a fit: Patients with early-stage prostate cancer or those who have not yet undergone treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatment strategies that help prostate cancer patients respond better to therapies.
How similar studies have performed: Previous research has shown promising results in reversing treatment resistance in other cancers using similar molecular targeting approaches.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Zaidi, Samir — Sloan-Kettering Inst Can Research
- Study coordinator: Zaidi, Samir
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.